Depo-Provera® Breast Cancer Risk
Depo-Provera®—also known as depot medroxyprogesterone acetate—is a form of hormonal birth control that’s injected into a woman’s thigh or buttocks every three months. The medication prevents pregnancy by increasing levels of progestin in a woman’s body. The U.S. Food and Drug Administration warns women that Depo-Provera may be linked to breast cancer.
If you used Depo-Provera and developed breast cancer, call Ferrer, Poirot & Wansbrough now at (800) 210-8503 or fill out a free initial consultation form. Our drug injury lawyers want to help you get compensation for your medical bills.
Breast Cancers Associated with Depo-Provera®
In 2012, researchers at the Fred Hutchinson Cancer Research Center found that women who use Depo-Provera for more than one year have a 2.2-fold increased risk of developing certain types of breast cancer, including:
Invasive Ductal Carcinoma (IDC)
IDC causes cancer cells to first grow in the milk ducts of the breast and then invade other parts of the breast tissue. The cancer, which is often detected as a lump, may remain in the breast tissue or spread to other tissues throughout the body.
Invasive Lobular Carcinoma (ILC)
ILC is a rare form of breast cancer that accounts for only 10 to 15 percent of diagnoses. Unlike IDC, ILC is usually detected as a mass or thickening in the breast tissue.
Get Our Experience on Your Side
At Ferrer, Poirot & Wansbrough, we’ve been helping drug injury victims for more than 30 years. Put your Depo-Provera injury claim in our hands. Our experience and industry knowledge means that we have the resources to build the strongest case possible for you. It’s our goal to get you the money you deserve—call today.
Depo-Provera® is a registered trademark of Pfizer, Inc.
This law firm is not associated with, sponsored by, or affiliated with the Fred Hutchinson Cancer Research Center, the U.S. Food and Drug Administration, or Pfizer, Inc.